Siga Technologies Inc (SIGA) |
|
7.16 -0.03 (-0.42%)
|
01-21 00:06 |
|
Open: |
7.19 |
Pre. Close: |
7.19 |
|
High:
|
7.2099 |
Low:
|
7.07 |
|
Volume:
|
188,643 |
Market Cap:
|
554M |
|
|
|
|
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security and infectious disease markets in the United States. Its lead product is TPOXX, an orally administered antiviral drug for the treatment of human smallpox disease caused by variola virus. The company was founded in 1995 and is headquartered in New York, New York. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
7.218 - 7.277 |
7.277 - 7.316 |
|
Low:
|
6.947 - 7.013 |
7.013 - 7.056 |
|
Close:
|
7.074 - 7.176 |
7.176 - 7.244 |
|
Technical analysis |
as of: 2021-01-20 4:52:10 PM |
|
Overall:
|
 |
| Stoxline posted a SELL today, same as yesterday. Downward movement continues. |
| Target: |
Six months: 8.74  One year: 9.11 |
| Support: |
Support1: 6.96 Support2: 5.79 |
| Resistance: |
Resistance1: 7.48 Resistance2: 7.80 |
| Pivot: |
7.38  |
| Moving Average: |
MA(5): 7.26 MA(20): 7.36
MA(100): 7.06 MA(250): 6.24 |
| MACD: |
MACD(12,26): 0.02 Signal(9): 0.07 |
| Stochastic oscillator: |
%K(14,3): 15.70 %D(3): 24.86 |
| RSI: |
RSI(14): 43.88 |
| 52-week: |
High: 8.10 Low: 3.96 Change(%): 37.4 |
| Average Vol(K): |
3-Month: 20857 10-Days: 18127 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.SIGA has closed above bottom band by 17.5%. Bollinger Bands are 20.2% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
|
Headline News |
Wed, 20 Jan 2021
Smallpox Treatment Market to Witness Massive Growth During 2021-2027 | Bavarian Nordic AS, Emergent BioSolutions Inc., Pfizer Inc., SIGA Technologies Inc., SIGA Technologies Inc. - Jumbo News
Wed, 20 Jan 2021
North America Biodefense Market Analysis, Trends, New Business Opportunities and Forecast 2021-2027 with Top Players Bavarian Nordic, Alnylam Pharmaceuticals, Inc., SIGA Technologies - NeighborWebSJ
Wed, 13 Jan 2021
SIGA Announces Public Health Agency of Canada Contract Award to Purchase Up To Approximately $33 Million of Oral TPOXX® - GlobeNewswire
Tue, 12 Jan 2021
Is SIGA Technologies, Inc.'s (NASDAQ:SIGA) Latest Stock Performance Being Led By Its Strong Fundamentals? - Simply Wall St
Wed, 06 Jan 2021
What is the Market's View on SIGA Technologies, Inc. (SIGA) Stock's Price and Volume Trends - InvestorsObserver
Tue, 22 Dec 2020
Read This Before Buying SIGA Technologies, Inc. (NASDAQ:SIGA) Shares - Simply Wall St
|
Financial Analysis |
| Growth |
 |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
|
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
 |
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
|
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Price to Book Value: |
Outperform |
Discounted cash flow: |
Outperform |
| Return on Assets: |
Outperform |
Price to Earnings: |
Outperform |
| Return on Equity: |
Outperform |
Debt to Equity: |
Neutral |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ |
| Sector: Healthcare |
| Industry: Biotechnology |
| Shares Out. (M) |
77 |
| Shares Float (M) |
39 |
|
% Held by Insiders
|
41.98 |
|
% Held by Institutions
|
38.47 |
|
Shares Short (K)
|
2,170 |
|
Shares Short P. Month (K)
|
2,500 |
Stock Financials |
|
EPS
|
0.390 |
|
EPS Est This Year
|
|
|
EPS Est Next Year
|
|
|
Book Value (p.s.)
|
1.450 |
|
Profit Margin
|
34.62 |
|
Operating Margin
|
59.27 |
|
Return on Assets (ttm)
|
19.7 |
|
Return on Equity (ttm)
|
29.4 |
|
Qtrly Rev. Growth
|
445.7 |
|
Gross Profit (p.s.)
|
0.141 |
|
Sales Per Share
|
1.182 |
|
EBITDA (p.s.)
|
0.707 |
|
Qtrly Earnings Growth
|
|
|
Operating Cash Flow (M)
|
11 |
|
Levered Free Cash Flow (M)
|
4 |
Stock Valuations |
|
PE Ratio
|
18.36 |
|
PEG Ratio
|
|
|
Price to Book value
|
4.94 |
|
Price to Sales
|
6.06 |
|
Price to Cash Flow
|
49.00 |
Stock Dividends |
|
Dividend
|
|
|
Forward Dividend
|
|
|
Dividend Yield
|
|
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
7 Binary Options
|
|
Your Ad Here
|
|
